Azithromycin reduces COPD exacerbation in a study

08/24/2011 | HealthDay News

A study of 1,142 people with advanced chronic obstructive pulmonary disease found that those who were given 250 milligrams of antibiotic azithromycin daily for one year had a 27% reduced risk of flare-ups compared with those who received placebo. Researchers noted in The New England Journal of Medicine that those who took the antibiotic also reported improvements in their quality of life.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY